Concepedia

Wylie S. Palmer

WS

Statistics

Publications

16

Citations

1.1K

H-Index

15

Active since

1994

Affiliations

University of California, Irvine(Current)

The University of Texas MD Anderson Cancer Center

La Roche College

Roche (United States)

Wylie S. Palmer is an author at University of California, Irvine specializing in chemistry, natural sciences, and drug discovery.

ORCID

Publications per year

1994–2020

16

Publications

16

The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies

Bhavatarini Vangamudi, Thomas A. Paul, Parantu K. Shah et al. · Cancer Research · 2015 · 270 citations

, , +13

Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor

Wylie S. Palmer, G. Poncet-Montange, Gang Liu et al. · Journal of Medicinal Chemistry · 2015 · 160 citations · Full text

, , +17

Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties

Michael Soth, Kang Le, Maria Emilia Di Francesco et al. · Journal of Medicinal Chemistry · 2020 · 91 citations · Full text

, , +16

Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation

Yuting Sun, Madhavi Bandi, Timothy Lofton et al. · Cell Reports · 2019 · 67 citations · Full text

, , +17

Synthesis of Silirenes by Palladium-Catalyzed Transfer of Silylene from Siliranes to Alkynes

Wylie S. Palmer, K. A. Woerpel · Organometallics · 1997 · 67 citations

, , +14

1–5 of 16